Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 39

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
 the outstanding shares of Common Stock present in person, by remote communication,
if applicable, or represented by proxy at the Annual Meeting approved the waiver of the Exchange Cap in connection with the July
Note and the CEF Purchase Agreement described in Note 10 —
“Stockholders’ Equity”.

February
Bridge Note

On
February 25, 2025, the Company issued an unsecured promissory note in the aggregate principal amount of $325 (the “February
Bridge Note”) to 3i, L.P., a Delaware limited partnership (the “Holder”), for a purchase price of $250, pursuant
to which the Company promises to pay the Holder or its registered assigns the principal sum of $325 or such amount equal to the
outstanding principal amount of the February Bridge Note together with interest. On May 12, 2025, the Company executed a first
amendment (the “February Bridge Note Amendment”) to the February Bridge Note. The February Bridge Note Amendment extends
the maturity date of the February Bridge Note from May 25, 2025 to September 30, 2025. Aside from extending the maturity date
of the February Bridge Note, the February Bridge Note Amendment does not amend, alter, restate or otherwise change the principal
terms and conditions of the February Bridge Note.

During
the three months ended September 30, 2025
the Company repaid $325 in principal and $7 of accrued
interest related to the February Bridge Note. As of September 30, 2025,
the February Bridge Note has been satisfied in full and no amounts remain outstanding.

May
Bridge Note

On
May 8, 2025, the Company issued an unsecured promissory note in the aggregate principal amount of $325 (the “May Bridge
Note”) to the Holder, for a purchase price of $250, pursuant to which the Company promises to pay the Holder or its registered
assigns the principal sum of $325 or such amount equal to the outstanding principal amount of the May Note together with interest.
During the three months ended September 30, 2025 the Company repaid $325 in
principal and $3 of accrued interest related
to the May Bridge Note. As of September 30, 2025, the
May Bridge Note has been satisfied in full and no amounts remain outstanding.

June
Bridge Note

On
June 23, 2025, the Company issued an unsecured promissory note in the aggregate principal